Poseida Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Poseida Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2021 to Q3 2024.
  • Poseida Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -21.5 %, a 48.8% increase year-over-year.
  • Poseida Therapeutics, Inc. annual Return On Assets for 2023 was -42.2 %, a 95.3% decline from 2022.
  • Poseida Therapeutics, Inc. annual Return On Assets for 2022 was -21.6 %, a 49.7% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -21.5 +20.6 +48.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -39.7 -30.9 -351% Apr 1, 2024 Jun 30, 2024
Q1 2024 -38.9 -24.6 -172% Jan 1, 2024 Mar 31, 2024
Q4 2023 -42.2 -20.6 -95.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 -42.1 -31.5 -297% Jul 1, 2023 Sep 30, 2023
Q2 2023 -8.8 +48.9 +84.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -14.3 +39.4 +73.3% Jan 1, 2023 Mar 31, 2023
Q4 2022 -21.6 +21.4 +49.7% Oct 1, 2022 Dec 31, 2022
Q3 2022 -10.6 +40.8 +79.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -57.7 -13.8 -31.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -53.7 -12 -28.7% Jan 1, 2022 Mar 31, 2022
Q4 2021 -43 Oct 1, 2021 Dec 31, 2021
Q3 2021 -51.4 Jul 1, 2021 Sep 30, 2021
Q2 2021 -43.9 Apr 1, 2021 Jun 30, 2021
Q1 2021 -41.7 Jan 1, 2021 Mar 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.